Cancer Center News

Members of the CHOP Cancer Center team work to ensure that our patients’ and families’ transition to outpatient care is smooth and successful.

The Psychosocial Services Program in the Division of Oncology at Children’s Hospital of Philadelphia provides comprehensive psychosocial services for children with cancer and members of their families.

CHOP recently launched a Bone and Soft Tissue Tumor Program, a collaboration between teams from Orthopedics and Oncology.

CHOP's revolutionary T-cell immunotherapy was featured at “Cellular Horizons: The Third International Conference on the Progress of Regenerative Medicine and Its Cultural Impact,” an exclusive international event at the Vatican.

The Children’s Oncology Group (COG) high risk acute lymphoblastic leukemia (HR ALL) TARGET Project is a large collaborative effort led by Stephen Hunger, MD.

CHOP is working to improve personalized cell therapy for children. Using younger T cells may offer better results against certain types of leukemia and lymphoma.

A CHOP oncologist co-led an international study showing that an abnormal fused gene drives children’s brain tumors by using three different biological mechanisms. 

After children with leukemia receive chemotherapy, are they better off remaining in the hospital, or going home? CHOP is leading a multicenter study of both safety and family preferences.

CHOP’s new Center for Data Driven Discovery in Biomedicine aims to harness and broadly share biomedical information to more quickly benefit child patients. 

CHOP researchers have identified a powerful new drug with “unparalleled” strength against refractory types of neuroblastoma.